Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Journal of Medicinal Chemistry
|
February 21, 2003
Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties
Kristin Brachwitz, Burkhardt Voigt, Laurent Meijer, et al.
Chemmedchem
|
December 9, 2010
Discovery of 4-benzylamino-substituted α-carbolines as a novel class of receptor tyrosine kinase inhibitors
Martin Krug, Kanin Wichapong, German Erlenkamp, et al.
Journal of Medicinal Chemistry
|
August 22, 2008
Novel insight in structure-activity relationship and bioanalysis of P-glycoprotein targeting highly potent tetrakishydroxymethyl substituted 3,9-diazatetraasteranes
Claudius Coburger, Jörg Wollmann, Christiane Baumert, et al.
Future Medicinal Chemistry
|
December 24, 2021
Discovery of a novel class of small-molecule antibacterial agents against <i>Staphylococcus aureus</i>
David Kreutzer, Robin Gehrmann, Annámaria Kincses, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 9, 2012
Multitargeted drug development: Discovery and profiling of dihydroxy substituted 1-aza-9-oxafluorenes as lead compounds targeting Alzheimer disease relevant kinases
Volkmar Tell, Max Holzer, Lydia Herrmann, et al.
Future Medicinal Chemistry
|
August 3, 2022
Novel effective small-molecule inhibitors of protein kinases related to tau pathology in Alzheimer's disease
Ansgar Opitz, Lisa-Marie Seitz, Vladimir Krystof, et al.
Bioorganic & Medicinal Chemistry
|
July 6, 2010
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators
Claudius Coburger, Jörg Wollmann, Martin Krug, et al.
Drug Design, Development and Therapy
|
January 23, 2019
Antistaphylococcal evaluation of indole-naphthalene hybrid analogs
Kerolos Ashraf, Kaveh Yasrebi, Emmanuel Tola Adeniyi, et al.
Bioorganic & Medicinal Chemistry
|
December 4, 2012
Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties
Christiane Baumert, Marianne Günthel, Sören Krawczyk, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 22, 2014
Discovery of 4-anilino α-carbolines as novel Brk inhibitors
Kazem Ahmed Mahmoud, Martin Krug, Tom Wersig, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Journal of Medicinal Chemistry
|
February 21, 2003
Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties
Kristin Brachwitz, Burkhardt Voigt, Laurent Meijer, et al.
Chemmedchem
|
December 9, 2010
Discovery of 4-benzylamino-substituted α-carbolines as a novel class of receptor tyrosine kinase inhibitors
Martin Krug, Kanin Wichapong, German Erlenkamp, et al.
Journal of Medicinal Chemistry
|
August 22, 2008
Novel insight in structure-activity relationship and bioanalysis of P-glycoprotein targeting highly potent tetrakishydroxymethyl substituted 3,9-diazatetraasteranes
Claudius Coburger, Jörg Wollmann, Christiane Baumert, et al.
Future Medicinal Chemistry
|
December 24, 2021
Discovery of a novel class of small-molecule antibacterial agents against <i>Staphylococcus aureus</i>
David Kreutzer, Robin Gehrmann, Annámaria Kincses, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 9, 2012
Multitargeted drug development: Discovery and profiling of dihydroxy substituted 1-aza-9-oxafluorenes as lead compounds targeting Alzheimer disease relevant kinases
Volkmar Tell, Max Holzer, Lydia Herrmann, et al.
Future Medicinal Chemistry
|
August 3, 2022
Novel effective small-molecule inhibitors of protein kinases related to tau pathology in Alzheimer's disease
Ansgar Opitz, Lisa-Marie Seitz, Vladimir Krystof, et al.
Bioorganic & Medicinal Chemistry
|
July 6, 2010
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators
Claudius Coburger, Jörg Wollmann, Martin Krug, et al.
Drug Design, Development and Therapy
|
January 23, 2019
Antistaphylococcal evaluation of indole-naphthalene hybrid analogs
Kerolos Ashraf, Kaveh Yasrebi, Emmanuel Tola Adeniyi, et al.
Bioorganic & Medicinal Chemistry
|
December 4, 2012
Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties
Christiane Baumert, Marianne Günthel, Sören Krawczyk, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 22, 2014
Discovery of 4-anilino α-carbolines as novel Brk inhibitors
Kazem Ahmed Mahmoud, Martin Krug, Tom Wersig, et al.
Page
of 7